![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Institute of Anatomy and Cell Biology, University of Würzburg, Würzburg, Germany
Abstract
The affinity of corticosterone to organic cation transporters (OCTs) is subtype- and species-dependent. For example, the IC50 values for corticosterone inhibition of cation uptake by transporters rOCT1 and rOCT2 are 
150 and 4 µM, respectively. By introducing domains and amino acids from rOCT2 into rOCT1, we found that the exchange of three amino acids in the presumed 10th transmembrane 
helix is sufficient to increase the affinity of rOCT1 for corticosterone to that of rOCT2. Replacement of these amino acids in rOCT2 decreased the affinity for corticosterone. These amino acids (Ala443, Leu447, and Gln448 in rOCT1 and Ile443, Tyr447, and Glu448 in rOCT2) are probably located within the substrate binding region because in rOCT1 mutants, the Km values for uptake of tetraethylammonium (TEA) and 1-methyl-4-phenylpyridinium (MPP) were decreased in parallel with a decrease of the IC50 values for the inhibition of cation uptake by corticosterone. In mutant rOCT1(L447Y/Q448E), the IC50 value for the inhibition of [3H]MPP (0.1 µM) uptake by corticosterone (24 ± 4 µM) was significantly higher compared with the IC50 value for inhibition of [14C]TEA (10 µM) uptake (5.3 ± 1.7 µM). This finding suggests an allosteric interaction between transported cation and corticosterone. Because this substrate-specific effect cannot be explained by differential replacement of corticosterone by MPP versus TEA and was observed after point mutations within the presumed substrate region, the data suggest that MPP or TEA bind to the substrate binding region simultaneously with corticosterone and cause a short-range allosteric effect on the corticosterone binding site.
Address correspondence to: Dr. Hermann Koepsell, Institute of Anatomy and Cell Biology, Koellikerstr. 6, 97070 Würzburg, Germany. E-mail: hermann{at}koepsell.de
This article has been cited by other articles:
|
|
 |
|
  D. Gorbunov, V. Gorboulev, N. Shatskaya, T. Mueller, E. Bamberg, T. Friedrich, and H. Koepsell High-Affinity Cation Binding to Organic Cation Transporter 1 Induces Movement of Helix 11 and Blocks Transport after Mutations in a Modeled Interaction Domain between Two Helices Mol. Pharmacol., January 1, 2008; 73(1): 50 - 61. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Sturm, V. Gorboulev, D. Gorbunov, T. Keller, C. Volk, B. M. Schmitt, P. Schlachtbauer, G. Ciarimboli, and H. Koepsell Identification of cysteines in rat organic cation transporters rOCT1 (C322, C451) and rOCT2 (C451) critical for transport activity and substrate affinity Am J Physiol Renal Physiol, September 1, 2007; 293(3): F767 - F779. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M. Pelis, Y. Dangprapai, T. M. Wunz, and S. H. Wright Inorganic mercury interacts with cysteine residues (C451 and C474) of hOCT2 to reduce its transport activity Am J Physiol Renal Physiol, May 1, 2007; 292(5): F1583 - F1591. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Zhou, L. Xia, K. Engel, and J. Wang Molecular Determinants of Substrate Selectivity of a Novel Organic Cation Transporter (PMAT) in the SLC29 Family J. Biol. Chem., February 2, 2007; 282(5): 3188 - 3195. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Perry, N. Dembla-Rajpal, L. A. Hall, and J. B. Pritchard A Three-dimensional Model of Human Organic Anion Transporter 1: AROMATIC AMINO ACIDS REQUIRED FOR SUBSTRATE TRANSPORT J. Biol. Chem., December 8, 2006; 281(49): 38071 - 38079. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M. Pelis, X. Zhang, Y. Dangprapai, and S. H. Wright Cysteine Accessibility in the Hydrophilic Cleft of Human Organic Cation Transporter 2 J. Biol. Chem., November 17, 2006; 281(46): 35272 - 35280. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Biermann, D. Lang, V. Gorboulev, H. Koepsell, A. Sindic, R. Schroter, A. Zvirbliene, H. Pavenstadt, E. Schlatter, and G. Ciarimboli Characterization of regulatory mechanisms and states of human organic cation transporter 2 Am J Physiol Cell Physiol, June 1, 2006; 290(6): C1521 - C1531. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Ciarimboli, T. Ludwig, D. Lang, H. Pavenstadt, H. Koepsell, H.-J. Piechota, J. Haier, U. Jaehde, J. Zisowsky, and E. Schlatter Cisplatin Nephrotoxicity Is Critically Mediated via the Human Organic Cation Transporter 2 Am. J. Pathol., December 1, 2005; 167(6): 1477 - 1484. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Zhang, N. V. Shirahatti, D. Mahadevan, and S. H. Wright A Conserved Glutamate Residue in Transmembrane Helix 10 Influences Substrate Specificity of Rabbit OCT2 (SLC22A2) J. Biol. Chem., October 14, 2005; 280(41): 34813 - 34822. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Popp, V. Gorboulev, T. D. Muller, D. Gorbunov, N. Shatskaya, and H. Koepsell Amino Acids Critical for Substrate Affinity of Rat Organic Cation Transporter 1 Line the Substrate Binding Region in a Model Derived from the Tertiary Structure of Lactose Permease Mol. Pharmacol., May 1, 2005; 67(5): 1600 - 1611. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Burckhardt Polyspecific Organic Cation Transport: Insights into the Substrate Binding Site Mol. Pharmacol., May 1, 2005; 67(5): 1391 - 1392. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
